No abstract

The aim of this study was to evaluate the passive transfer (PT) status of goat kids by Brix refractometry and compare the results with other semiquantitative tests (total protein-TP, glutaraldehyde coagulation test-GCT, and gamma-glutamyltransferase-GGT) and immunoglobulin G (IgG). The study was conducted on 75 goat kids born from 47 Saanen goats. The blood samples were collected from the kids on day 0 (presuckling) and on the 1st, 2nd, and 3rd days after birth. The Brix% and TP concentrations were measured with refractometers, and GGT activity was measured using a dry chemistry system. The duration of the GCT was determined in the first 60 min. The serum IgG concentration was measured by goat IgG ELISA kit. On the 1st and 2nd days, serum Brix% in the kids was measured as 9.33 ± 0.17% and 9.17 ± 0.14%, respectively. In the 1st and 2nd day serum samples of the kids, IgG was 817.76 ± 37.34 mg/dL and 1173.29 ± 47.81 mg/dL, respectively, and GGT was 1298.07 ± 133.29 IU/L and 692.26 ± 79.86 IU/L, respectively. The Brix refractometer was found to be more sensitive for detection of PT status in kids on the first and second days after birth, such as TP and GCT, whereas GGT, as an early indicator of PT, was useful only on the first day after birth. We conclude that the Brix refractometer could be used to determine the PT status in goat kids and Brix measurements lower than 8.6%, 9.2%, and 9.3% indicate failure of PT in 1-, 2-, and 3-day-old kids, respectively.

The aim of this study was to compare the clinical efficacy of a single-dose of gamithromycin (GM) or marbofloxacin (MR) in kids with naturally occurring pneumonia. Thirty-six kids, aged 2–2.5 months, with body weight ranging from 12 kg to 18 kg were presented with clinical signs of pneumonia. The most prominent clinical findings were an increase in the respiratory rate, crackling lung sounds on auscultation, coughing, nasal discharge and an increased rectal temperature. Mannheimia haemolytica and Mycoplasma spp. colonies were isolated from microbiological examination of six transtracheal washes and lung tissues of one necropsied kid. The severity of pneumonia was evaluated by using cumulative clinical score (CCS). The CCS of the 36 kids used in the study were four and above. Kids were randomly divided into two equal groups; the GM group received a single subcutaneous dose of GM at a dosage of 6 mg/kg and the MR group received MR intramuscularly at a dosage of 8 mg/kg as a single-dose. No side effects related to the drugs were detected in either group. All 36 kids were clinically examined 3 weeks after the initiation of the treatment. Clinical signs in both groups were almost completely absent at the end of the study. A single administration of GM or MR was successfully used in the treatment of kids with pneumonia.

No abstract

This study aimed to investigate the effect of using menbutone in addition to ammonium molybdate on liver enzymes in sheep naturally poisoned with copper. Merino lambs (n = 30), naturally poisoned with copper and which also had high liver enzyme levels, were divided into two groups, each with 15 lambs. The AM + MEN group received ammonium molybdate and menbutone and the AM group received only ammonium molybdate solution. Both groups received 1.7% ammonium molybdate solution (1 mL per 10 kg body weight [BW]) subcutaneously on 0, 2nd and 4th days of the study. Menbutone (Genabil®, Boehringer Ingelheim, Germany) was administered intramuscularly at a dose of 10 mg/kg BW on days 0 and 2, in addition to ammonium molybdate in the AM + MEN group. Blood samples were collected on days 0 and 7, and aspartate aminotransferase (AST), gamma-glutamyltranspeptidase (GGT) and creatinine levels were evaluated. Over 7 days, AST levels decreased from 351.04 AE 63.50 IU/L to 286.40 AE 55.68 IU/L in the AM group (P > 0.05) and from 425.00 AE 119.25 IU/L to 240.83 AE 29.62 IU/L in the AM + MEN group (P ≤ 0.05). GGT levels decreased from 121.16 AE 15.88 IU/L to 110.39 AE 10.13 IU/L in the AM group (P > 0.05) and 124.52 AE 15.50 to 98.60 AE 9.08 IU/L in the AM + MEN group (P ≤ 0.05). Based on these findings, the use of menbutone, in addition to ammonium molybdate, has significantly reduced the level of liver enzymes.